The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
EAHP’s 2023 Medicines Shortages report has been published. Find the report here.
Between March and May 2023, EAHP collected data for the 2023 Shortage Survey. It focused on medicinal products and medical devices and targetted the impact of both medicine and medical device shortages in the hospital environment. In addition to hospital pharmacists, EAHP sought input from patients and all healthcare professionals working in hospitals.
Thank you to those that participated!
EAHP has been advocating on the issue of medicine shortages for more than a decade. Five surveys were conducted by EAHP in 2013, 2014, 2018, 2019 and 2020, with the last one focusing also on the pandemic preparedness of pharmacists. The results of these surveys have provided an overview of the severity of the problem as well as its impact on overall patient care.
Medicine shortages cause serious problems for patients, health professionals and health systems. Hospital pharmacists play a key role in managing medicine shortages within hospitals, but they are not the only stakeholders which are affected. This is why EAHP has invited other stakeholders, including healthcare professionals and patients, to provide their input on how shortages are affecting them.
Translations were made available in the following languages:
- Czech translation
- French translation
- Hungarian translation
- Romanian translation
- Serbian translation (Latin alphabet | Cyrillic alphabet)
- Spanish translation
You can also find the EAHP Statement on the European Commission’s Communication on addressing medicine shortages in the EU HERE.